EUVIMEDEUVIMED entdecken
Open Access

Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden

Xin Hu iD, Clara Cai, Sara Arshad iD, Janeane N Anderson iD, Mylin A Torres, Gregory A Vidal iD, Lee Schwartzberg iD, Ilana Graetz iD

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Xin Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Emory University, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Black or African American, White People, Racism. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adjuvant endocrine therapy reduces breast cancer recurrence, but symptom burden contributes to nonadherence, particularly among Black women. We examined how patient sociodemographic factors and perceived discrimination are associated with symptoms and Black-White differences in symptoms during early treatment course of adjuvant endocrine therapy.

Methods

We conducted a post hoc analysis using survey data collected at study enrollment in the THRIVE trial from November 15, 2018, to June 11, 2021, among women with early-stage breast cancer. Symptom burden was assessed by the Functional Assessment of Cancer Therapy–Endocrine Subscale within 8 weeks of adjuvant endocrine therapy initiation. Covariates included sociodemographic and clinical information and perceived discrimination. Multivariable regressions and Kitagawa–Oaxaca–Blinder decomposition evaluated how these patient characteristics are associated with Black-White differences in symptoms.

Results

Among 272 participants, 35.7% self-identified as Black and 64.3% as White. Black women reported more symptoms (lower Functional Assessment of Cancer Therapy–Endocrine Subscale scores) than White women (60.7 vs 64.3, P = .004) and similar discrimination scores (5.44 vs 5.54, P = .17). Experiencing less discrimination (ie, each unit increase in discrimination score, 1.93, 95% confidence interval [CI] = 0.08 to 3.78), older age groups (65-83 vs 30-49 years: 4.84, 95% CI = 1.15 to 8.54), and higher income (≥400% vs <200% federal poverty level = 5.72, 95% CI = 2.12 to 9.33) was associated with lower symptom burden. Decomposition analyses attributed 84.6% of Black-White symptom differences to patient characteristics, with income explaining the largest proportion, while perceived discrimination did not explain symptom burden differences.

Conclusions

Black women experienced higher early symptoms during adjuvant endocrine therapy. Although perceived discrimination was associated with greater symptom burden, it did not clinically or statistically significantly explain Black-White differences in symptoms. Income explained the largest portion of Black-White symptom differences. Addressing income inequality is essential for equitable symptom management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBlack or African AmericanWhite PeopleRacismHealthcare DisparitiesHumansFemaleMiddle AgedAgedAdultSocioeconomic FactorsAntineoplastic Agents, HormonalCost of IllnessSociodemographic FactorsChemotherapy, AdjuvantSymptom BurdenWhite

Substanzen

Antineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Radiation Oncology, Emory University, Atlanta, GA, United States.
  • Department of Health Policy and Management, Emory University, Atlanta, GA, United States.
  • Winship Cancer Institute, Emory University, Atlanta, GA, United States.
  • Emory College of Arts and Sciences, Emory University, Atlanta, GA, United States.
  • Department of Community and Population Health, University of Tennessee Health Science Center, Memphis, TN, United States.
  • West Cancer Center and Research Institute and Lee S Schwartzberg's Research Center, Germantown, TN, United States.

ORCID-Profile: Xin Hu, Sara Arshad, Janeane N Anderson, Gregory A Vidal, Lee Schwartzberg, Ilana Graetz

Förderung

  • NCI NIH HHS
  • NIH
  • National Cancer Institute

Zitieren

APA

Hu, X., Cai, C., Arshad, S., Anderson, J. N., Torres, M. A., Vidal, G. A., Schwartzberg, L., & Graetz, I. (2025). Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf301

Vancouver

Hu X, Cai C, Arshad S, Anderson JN, Torres MA, Vidal GA, et al. Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf301

BibTeX
@article{Hu2025,
  author = {Hu, Xin and Cai, Clara and Arshad, Sara and Anderson, Janeane N and Torres, Mylin A and Vidal, Gregory A and Schwartzberg, Lee and Graetz, Ilana},
  title = {Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf301}
}
Kostenlos starten →